Financial Analysis: Global Wholehealth Partners (OTCMKTS:GWHP) & MariMed (OTCMKTS:MRMD)

MariMed (OTCMKTS:MRMDGet Free Report) and Global Wholehealth Partners (OTCMKTS:GWHPGet Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.

Institutional and Insider Ownership

0.2% of MariMed shares are owned by institutional investors. 17.3% of MariMed shares are owned by insiders. Comparatively, 10.3% of Global Wholehealth Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares MariMed and Global Wholehealth Partners”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MariMed $159.83 million 0.17 -$14.48 million ($0.03) -2.33
Global Wholehealth Partners N/A N/A N/A ($0.05) N/A

Global Wholehealth Partners has lower revenue, but higher earnings than MariMed. MariMed is trading at a lower price-to-earnings ratio than Global Wholehealth Partners, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares MariMed and Global Wholehealth Partners’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MariMed -7.82% -5.00% -1.29%
Global Wholehealth Partners N/A N/A N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for MariMed and Global Wholehealth Partners, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MariMed 0 2 0 0 2.00
Global Wholehealth Partners 0 0 0 0 0.00

Given Global Wholehealth Partners’ higher probable upside, analysts clearly believe Global Wholehealth Partners is more favorable than MariMed.

Summary

MariMed beats Global Wholehealth Partners on 5 of the 9 factors compared between the two stocks.

About MariMed

(Get Free Report)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

About Global Wholehealth Partners

(Get Free Report)

Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases. The company was incorporated in 2013 and is based in Newport Beach, California.

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.